Skip to content
    BRV Capital Management logo

    BRV Capital Management

    Hong KongFounded 1998

    BRV Capital Management is a global growth investment platform and the Asia-based, tech-focused growth equity investment arm of BlueRun Ventures. The firm targets category winners that are clearly the most competitive within their respective industries, investing in growth-stage companies.

    Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $51.1M (across 20 rounds with reported amounts).

    Find people at BRV Capital Management on Goldilocks AI

    Portfolio

    27

    Fund Size

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    JC

    Jeff Chu

    Senior Managing Director

    YC

    Yeemin Chung

    Senior Managing Director

    JJ

    Jaeyoon Jung

    Managing Director

    KA

    Key Arm Suh

    Executive Director

    LY

    Larry Yea Lam Lee

    Principal

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    28 investments
    CompanyRoundAmountDate
    PlayAd AI logoPlayAd AIPre-Seed$5.4MJan 2026
    Observable Space logoObservable SpaceSeries A$90MJan 2026
    ZZettabyteGrowthSep 2025
    WWRTNSeries BMar 2025
    Subtle Medical logoSubtle MedicalSeries B$10MJul 2024
    DreamBig logoDreamBigSeries B$75MJul 2024
    WRTN TECHNOLOGIES INC. logoWRTN TECHNOLOGIES INC.Series BJun 2024
    WWRTNSeries BJun 2024
    Silicon Box logoSilicon BoxSeries BJan 2024
    MMezzion PharmaUnknown$40MApr 2023
    Green Labs logoGreen LabsUnknown$38.4MMar 2023
    OP3N logoOP3NSeries A$28MMar 2023
    EEst MediaUnknown$28MMar 2023
    VVerismo TherapeuticsSeed$7MFeb 2023
    KKey ProteoSeries A$5MJan 2023
    LLine Man WongnaiSeries BSep 2022
    Swiftly logoSwiftlySeries C$100MSep 2022
    Bucketplace logoBucketplaceSeries D$182MMay 2022
    Neosapience logoNeosapienceSeries B$21.5MFeb 2022
    Immunefi logoImmunefiSeed$5.5MOct 2021
    Upgrade logoUpgradeSeries E$105MAug 2021
    BBunjangUnknownJan 2020
    Arvelle logoArvelleSeries A$180MFeb 2019
    OpenBucks logoOpenBucksSeries A$4.8MJul 2012
    AArvelle TherapeuticsUnknown
    Page 1 of 2

    Top Co-Investors

    Last updated: 8 September 2026